<DOC>
	<DOCNO>NCT00885118</DOCNO>
	<brief_summary>The objective trial evaluate pharmacodynamics , pharmacokinetics , safety , tolerability daily oral administration BI 10773 administer 28 day Japanese patient T2DM .</brief_summary>
	<brief_title>4 Weeks Treatment With Empagliflozin ( BI 10773 ) Japanese Type 2 Diabetic Patients ( T2DM )</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Empagliflozin</mesh_term>
	<criteria>Inclusion criterion : 1 . Japanese male female patient T2DM treat diet exercise alone one hypoglycaemic drug glitazones . 2 . Hemoglobin A1c ( HbA1c ) screening ( Visit 1 ) For patient treat 1 oral antidiabetic drug : HbA1c 6.5 % 9.0 % . For patient treat antidiabetic drug : HbA1c 7.0 % 10.0 % . 3 . Age 20 70 year 4 . Body mass index ( BMI ) between18.0 40.0 kg/m2 5 . Signed date write informed consent admission trial accordance Good Clinical Practice ( GCP ) local legislation . Exclusion criterion : 1 . Antidiabetic treatment insulin glitazones within 3 month obtain informed consent 1 oral hypoglycaemic agent time inform consent 2 . Fasted blood glucose &gt; 240 mg/dL ( &gt; 13.3 mmol/L ) randomly determine blood glucose level &gt; 400 mg/dL ( 22.2 mmol/L ) 2 consecutive day washout period . 3 . Myocardial infarction , stroke , transient ischaemic attack within 6 month inform consent . 4 . Clinically relevant concomitant disease T2DM , hyperlipidaemia , medically treat hypertension first administration Renal insufficiency ( calculate estimate glomerular filtration rate &lt; 60 ) Cardiac insufficiency New York Heart Association ( NYHA ) IIIV know cardiovascular disease include hypertension &gt; 160/95 mmHg , Neurological disorder ( epilepsy ) psychiatric disorder Acute clinically relevant chronic infection ( e.g. , human immunodeficiency virus , hepatitis , repeat urogenital infection ) Any gastrointestinal , hepatic , respiratory , endocrine , immunological disorder 5 . Patients treatment concomitant medication except follow drug time inform consent . : Statins . Antihypertensives ( diuretic allow ) alphaBlockers benign prostate hypertrophy Occasional use acetylsalicylic acid , ibuprofen , paracetamol 6 . Additional inclusion/exclusion criterion apply</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>November 2014</verification_date>
</DOC>